AstraZeneca Posts Rise in H1 Profit, Revenue

02:24 AM EDT, 07/27/2026 (MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) said Monday that its profit and total revenue grew year over year for the first half. Profit attributable to owners of the parent for the six months ended June 30 was $5.59 billion, compared with $5.37 billion earlier. EPS moved to $3.58 from $3.44. The drugmaker's total revenue was $30.67 billion, compared with $28.05 billion a year ago. Meanwhile, the board declared a dividend of $1.06 per share for the first half, payable Sept. 8 to shareholders on record Aug. 7. It paid $1.03 per share in the year-ago period. For the full year, AstraZeneca maintained its guidance of mid-to-high single-digit growth in total revenue, alongside a low-double-digit increase in core EPS.